8th Circ. Won't Pause FTC's Insulin Pricing Case
By Matthew Perlman · March 20, 2025, 8:04 PM EDT
The Eighth Circuit refused Thursday to pause the Federal Trade Commission's in-house case accusing Caremark Rx, Express Scripts and OptumRx of artificially inflating insulin prices while the pharmacy benefit managers challenge...
To view the full article, register now.
Try a seven day FREE Trial
Already a subscriber? Click here to login